INACTIVE
INGREDIENT | ROUTE;DOSAGE FORM | CAS
NUMBER | UNII | MAXIMUM
POTENCY |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; CAPSULE | | Z78RG6M2N2 | 80.25MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; CAPSULE, SUSTAINED ACTION | | Z78RG6M2N2 | 336MG |
|
开工令HYPROMELLOSE 2208 (15000 MPA.S) | nnd ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN | | Z78RG6M2N2 | 2.771MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET | | Z78RG6M2N2 | 86MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, COATED | | Z78RG6M2N2 | 33MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, CONTROLLED RELEASE | | Z78RG6M2N2 | 7.8MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, EXTENDED RELEASE | | Z78RG6M2N2 | 320MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION | | Z78RG6M2N2 | 480MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION, COATED | | Z78RG6M2N2 | 94MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION, FILM COATED | | Z78RG6M2N2 | 200MG |
|
HYPROMELLOSE 2208 (15000 MPA.S) | VAGINAL; EMULSION, CREAM | | Z78RG6M2N2 | 0.3% |
|
HYPROMELLOSE 2208 (60000 MPA.S) | ORAL; TABLET, EXTENDED RELEASE | | 2F7T07H9ZD | 175MG |
|
HYPROMELLOSE 2208 (80000-120000 CPS) | ORAL; TABLET, EXTENDED RELEASE | 9004653 | VM7F0B23ZI | 54MG |
|
HYPROMELLOSE 2910 (15 MPA.S) | ORAL; TABLET | | 36SFW2JZ0W | 52.5MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | NASAL; SOLUTION, SPRAY | | 288VBX44JC | 0.1% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | NASAL; SPRAY | | 288VBX44JC | 0.1% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | NASAL; SPRAY, METERED | | 288VBX44JC | 0.1% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | OPHTHALMIC; SOLUTION | | 288VBX44JC | 0.5% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | OPHTHALMIC; SUSPENSION | | 288VBX44JC | 0.5% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | OPHTHALMIC; SUSPENSION, DROPS | | 288VBX44JC | 0.5% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE | | 288VBX44JC | 40.5519MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, DELAYED ACTION | | 288VBX44JC | 33.42MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, ENTERIC COATED PELLETS | | 288VBX44JC | 13.82MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, EXTENDED RELEASE | | 288VBX44JC | 10.6MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, HARD GELATIN | | 288VBX44JC | 2MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, SUSTAINED ACTION | | 288VBX44JC | 10.88MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN | | 288VBX44JC | 4.772MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; GRANULE, FOR ORAL SUSPENSION | | 288VBX44JC | 26.6MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; POWDER, FOR RECONSTITUTION | | 288VBX44JC | 1.593% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; POWDER, FOR SUSPENSION | | 288VBX44JC | 3% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; SOLUTION, SYRUP | | 288VBX44JC | 2.4% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; SUSPENSION | | 288VBX44JC | 0.5% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; SYRUP | | 288VBX44JC | 2.25% |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET | | 288VBX44JC | 54MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED | | 288VBX44JC | 16.76MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | | 288VBX44JC | 11.8MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, COATED | | 288VBX44JC | 29.25MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, CONTROLLED RELEASE | | 288VBX44JC | 20MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, DELAYED ACTION | | 288VBX44JC | 4.47MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, DELAYED ACTION, ENTERIC COATED | | 288VBX44JC | 19MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, ENTERIC COATED PARTICLES | | 288VBX44JC | 445MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, EXTENDED RELEASE | | 288VBX44JC | 150MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, FILM COATED | | 288VBX44JC | 60MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, MULTILAYER, COATED | | 288VBX44JC | 22MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | | 288VBX44JC | 7MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION | | 288VBX44JC | 250MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION, COATED | | 288VBX44JC | 6MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL; TABLET, SUSTAINED ACTION, FILM COATED | | 288VBX44JC | 54MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL-21; TABLET | | 288VBX44JC | 0.75MG |
|
HYPROMELLOSE 2910 (15000 MPA.S) | ORAL-28; TABLET | | 288VBX44JC | 0.75MG |
|
HYPROMELLOSE 2910 (5 MPA.S) | ORAL; TABLET | | R75537T0T4 | 2.02MG |
|
HYPROMELLOSE 2910 (6 MPA.S) | ORAL; TABLET | | 0WZ8WG20P6 | 4.51MG |
|
HYPROMELLOSE 2910 (6 MPA.S) | ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED | | 0WZ8WG20P6 | 6.43MG |
|
HYPROMELLOSE PHTHALATE | ORAL; CAPSULE | 9050311 | N/A | 16.8MG |
|
HYPROMELLOSE PHTHALATE | ORAL; CAPSULE, COATED PELLETS | 9050311 | N/A | 13.26MG |
|
HYPROMELLOSE PHTHALATE | ORAL; CAPSULE, ENTERIC COATED PELLETS | 9050311 | N/A | 97.2MG |
|
HYPROMELLOSE PHTHALATE | ORAL; CAPSULE, EXTENDED RELEASE | 9050311 | N/A | 37.8MG |
|
HYPROMELLOSE PHTHALATE | ORAL; CAPSULE, SUSTAINED ACTION | 9050311 | N/A | 19.63MG |
|
HYPROMELLOSE PHTHALATE | ORAL; GRANULE, FOR SUSPENSION | 9050311 | N/A | 302.4MG |
|
HYPROMELLOSE PHTHALATE | ORAL; TABLET | 9050311 | N/A | 104.4MG |
|
HYPROMELLOSE PHTHALATE | ORAL; TABLET, DELAYED ACTION | 9050311 | 西安翻译公司N/A | 12.7MG |
|
HYPROMELLOSE PHTHALATE 高中国际部 | ORAL; TABLET, DELAYED ACTION, ENTERIC COATED | 9050311 | N/A | 44.57MG |
|
HYPROMELLOSE PHTHALATE | ORAL; TABLET, ENTERIC COATED PARTICLES | 9050311 | N/A | 119.4MG |
|
HYPROMELLOSES | BUCCAL; TABLET | | 3NXW29V3WO | 24MG |
|
HYPROMELLOSES | IRRIGATION; SOLUTION | | 3NXW29V3WO | |
|
HYPROMELLOSES | OPHTHALMIC; GEL | | 3NXW29V3WO | 2.25% |
|
HYPROMELLOSES | OPHTHALMIC; SOLUTION | | 3NXW29V3WO | 50% |
|
HYPROMELLOSES | OPHTHALMIC; SOLUTION, DROPS | | 3NXW29V3WO | 0.6% |
|
HYPROMELLOSES | OPHTHALMIC; SUSPENSION | | 3NXW29V3WO | 0.5% |
|
HYPROMELLOSES | OPHTHALMIC; SUSPENSION, DROPS | | 3NXW29V3WO | 0.6% |
|
HYPROMELLOSES | ORAL; CAPSULE | | 3NXW29V3WO | 150MG |
| familiarity
HYPROMELLOSES | ORAL; CAPSULE, COATED PELLETS | | 3NXW29V3WO | 3.32MG |
|
HYPROMELLOSES | ORAL; CAPSULE, DELAYED ACTION | | 3NXW29V3WO | 6.808MG |
|
HYPROMELLOSES | ORAL; CAPSULE, DELAYED ACTION, COATED, HARD GELATIN | | 3NXW29V3WO | 20MG |
|
HYPROMELLOSES | ORAL; CAPSULE, DELAYED ACTION, ENTERIC COATED, SOFT GELATIN | | 3NXW29V3WO | |
|
HYPROMELLOSES | ORAL; CAPSULE, ENTERIC COATED PELLETS | | 3NXW29V3WO | 39.664MG |
|
HYPROMELLOSES | ORAL; CAPSULE, EXTENDED RELEASE | | 3NXW29V3WO | 79.4MG |
|
docketHYPROMELLOSES | ORAL; CAPSULE, HARD GELATIN | | 3NXW29V3WO | 73.9MG |
|
HYPROMELLOSES | ORAL; CAPSULE, SUSTAINED ACTION | | 3NXW29V3WO | 670.04MG |
|
HYPROMELLOSES | ORAL; CONCENTRATE | | 3NXW29V3WO | |
|
HYPROMELLOSES | ORAL; DROPS | | 3NXW29V3WO | 0.13% |
|
HYPROMELLOSES | ORAL; GRANULE, ENTERIC COATED | | 3NXW29V3WO | 17.2MG |
|
HYPROMELLOSES | ORAL; GRANULE, FOR ORAL SUSPENSION | | 3NXW29V3WO | 6.7MG |
|
HYPROMELLOSES | ORAL; MUCILAGE | | 3NXW29V3WO | 6.03MG |
|
HYPROMELLOSES | ORAL; POWDER, FOR ORAL SUSPENSION | | 3NXW29V3WO | 7.5% |
|
HYPROMELLOSES | ORAL; POWDER, FOR RECONSTITUTION | | 3NXW29V3WO | 15% |
|
HYPROMELLOSES | ORAL; POWDER, FOR SUSPENSION | | 3NXW29V3WO | 6.5% |
|
HYPROMELLOSES | ORAL; SOLUTION | | 3NXW29V3WO | 0.37% |
|
HYPROMELLOSES | ORAL; SUSPENSION | | 3NXW29V3WO | 3% |
|
HYPROMELLOSES | ORAL; SUSPENSION, LIQUID | | 3NXW29V3WO | 2.5% |
|
HYPROMELLOSES | ORAL; SYRUP | | 3NXW29V3WO | 18% |
|
HYPROMELLOSES | ORAL; TABLET | | 3NXW29V3WO | 444.4MG |
|
HYPROMELLOSES | ORAL; TABLET (IMMED./COMP. RELEASE), COATED | | 3NXW29V3WO | 4MG |
|
HYPROMELLOSES | ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED | | 3NXW29V3WO | 16MG |
|
HYPROMELLOSES | ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | | 3NXW29V3WO | 10MG |
|
HYPROMELLOSES | ORAL; TABLET, COATED | | 3NXW29V3WO | 245MG |
|
HYPROMELLOSES | ORAL; TABLET, CONTROLLED RELEASE | | 3NXW29V3WO | 65.7MG |
|
HYPROMELLOSES | ORAL; TABLET, DELAYED ACTION, ENTERIC COATED | | 3NXW29V3WO | 127.29MG |
|
HYPROMELLOSES | ORAL; TABLET, EXTENDED RELEASE | | 3NXW29V3WO | 400MG |
|
HYPROMELLOSES | ORAL; TABLET, FILM COATED | | 3NXW29V3WO | 536.8MG |
|
HYPROMELLOSES | ORAL; TABLET, MULTILAYER, EXTENDED RELEASE | | 3NXW29V3WO | 8.4MG |
|
HYPROMELLOSES | ORAL; TABLET, ORALLY DISINTEGRATING | | 3NXW29V3WO | 6.11MG |
|
HYPROMELLOSES | ORAL; TABLET, REPEAT ACTION | | 3NXW29V3WO | 60MG |
|
HYPROMELLOSES | ORAL; TABLET, SUSTAINED ACTION | | 3NXW29V3WO | 400MG |
|
HYPROMELLOSES | ORAL; TABLET, SUSTAINED ACTION, COATED | | 3NXW29V3WO | 221MG |
|
HYPROMELLOSES | ORAL; TABLET, SUSTAINED ACTION, FILM COATED | | 3NXW29V3WO | 58.333MG |
|
HYPROMELLOSES | ORAL; TABLET, SUSTAINED RELEASE, FILM COATED | | 3NXW29V3WO | 300MG | 出国辅导
|
HYPROMELLOSES | ORAL-21; TABLET | | 3NXW29V3WO | 8MG |
|
HYPROMELLOSES | ORAL-21; TABLET, COATED | | 3NXW29V3WO | 8MG |
|
HYPROMELLOSES | ORAL-28; TABLET | | 3NXW29V3WO | 8MG |
|
HYPROMELLOSES | ORAL-28; TABLET, COATED | | 3NXW29V3WO | 8MG |
|
HYPROMELLOSES | RECTAL; GEL | | 3NXW29V3WO | 4.35% |
|
HYPROMELLOSES | TOPICAL; EMULSION, CREAM | | 3NXW29V3WO | 0.1% |
七夕节 英文 |
HYPROMELLOSES | TOPICAL; EMULSION, LOTION | | 3NXW29V3WO | 0.1% |
|
六级考试真题HYPROMELLOSES | TOPICAL; JELLY | | 3NXW29V3WO | 2.5% |
|
HYPROMELLOSES | TOPICAL; LOTION | | 3NXW29V3WO | 0.1% |
|
HYPROMELLOSES | TOPICAL; PATCH | | 3NXW29V3WO | 12.14MG |
|
HYPROMELLOSES | TOPICAL; SOLUTION, DROPS | | 3NXW29V3WO | 西餐厅常用英语口语0.105% |
|
HYPROMELLOSES | VAGINAL; GEL | | 3NXW29V3WO | 3.5% |
|
HYPROMELLOSES | VAGINAL; TABLET | | 3NXW29V3WO | 5MG |
|
HYPROMELLOSES | VAGINAL; TABLET, FILM COATED | | 3NXW29V3WO | 54.212MG |
| | | | |
